サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：調剤薬局の世界市場：製品タイプ別、用途別、治療領域別、配合タイプ別、国別、地域別 - 産業分析、市場規模、市場シェア、2023年～2030年予測
市場調査レポート
商品コード
1351423

調剤薬局の世界市場：製品タイプ別、用途別、治療領域別、配合タイプ別、国別、地域別 - 産業分析、市場規模、市場シェア、2023年～2030年予測

Compounding Pharmacies Market, By Product Type, By Application, By Therapeutic areas, By Compounding Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 248 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
調剤薬局の世界市場：製品タイプ別、用途別、治療領域別、配合タイプ別、国別、地域別 - 産業分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2023年08月01日
発行: AnalystView Market Insights
ページ情報: 英文 248 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の調剤薬局の市場規模は、2022年は126億870万米ドルとなり、2023年から2030年にかけてCAGR 6.3%で拡大すると予想されています。

調剤薬局市場 - 市場力学

  • 慢性疾患の有病率の増加、高齢者人口の増加、平均寿命の向上が市場需要を促進する見込み。
  • 慢性疾患では長期的な治療が必要になることが多いです。調剤薬局は、患者独自の要求に医薬品を適合させ、投与量や剤形を最大化したり、特定の要求を持つ患者のために有効性や忍容性を改善したりすることができます。National Health Councilによると、一般的に不治の病で現在も進行中の慢性疾患は、約1億3,300万人のアメリカ人に影響を及ぼしており、これはこの国の総人口の40％以上に相当します。2020年までには、この数は推定1億5,700万人に増加し、8,100万人が複数の疾患を抱えていると予測されています。高齢者の増加に伴い、この年齢層向けの医療サービスや施設の面からも、老年医学の専門医療に対するニーズが高まっています。平均寿命が延びるにつれて、生活の質を確保するための予防医学が重視されるようになります。これにより、ウェルネス、栄養、検診産業が強化される可能性があります。発展途上国には大きな発展の機会があります。このような地域では、意識と所得水準が向上するにつれて、オーダーメイド治療のニーズが高まる可能性があります。しかし、調剤薬局が時折経験する厳しい規制監督には問題があります。それが市場成長の妨げとなっています。

調剤薬局市場 - セグメンテーション分析

  • 世界の調剤薬局市場は、製品タイプ、治療分野、用途、配合タイプ、地域に基づいてセグメント化されます。
  • 市場は製品タイプに基づいて7つのカテゴリーに分けられる：経口剤、局所剤、直腸剤、非経口剤、鼻腔剤、眼科剤、洗口剤です。市場を独占しているのは経口剤です。投与のしやすさ、患者のコンプライアンス、製剤の多様性（錠剤、カプセル剤、液剤、懸濁剤など）から、経口投与は依然として最も人気のある薬物送達手段の一つです。
  • 市場は治療領域別に4つのカテゴリーに分類される：疼痛管理、ホルモン補充療法（HRT）、皮膚科、専門薬です。ホルモン補充療法（HRT）分野が市場を独占しています。調剤薬局はホルモン補充療法（HRT）の分野で重要な役割を果たしています。HRTとは、更年期障害や男性更年期障害（「男性更年期障害」として知られることもある）、内分泌疾患などに伴う体内のホルモン異常を治療するためのホルモン剤です。
  • 市場は用途別に4つのカテゴリーに分類される：小児用、成人用、老人用、動物用です。小児用、成人用、老年用、動物用の4つに分類されます。老年用は市場を独占しており、予測期間中もその優位性を維持するとみられます。調剤薬局は老人ヘルスケア分野で重要な役割を果たしています。ポリファーマシー（多数の薬の服用）、加齢に伴う生理学的変化、特異的な薬物感受性、薬剤管理の問題などの要因から、高齢者層はしばしば独自の処方箋ニーズを抱えます。

調剤薬局市場 - 地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。北米は、配合剤に関する地域的な認知度の高さと医療施設の増加により、市場の成長を支配すると予想されます。長年にわたり、米国とカナダはヘルスケア・インフラに多額の投資を行ってきました。これは、病院だけでなく、専門クリニック、老人ホームなど、調合医薬品が有益となる介護環境も対象としています。The U.S. Health Care from a Global Perspectiveでは、2021年には米国が国内総生産（GDP）の17.8％を医療に費やすと予測しており、これはOECD加盟国の平均の約2倍に相当します。欧州は、高い認知度、規制の明確さ、経済力、技術革新により、調剤薬局にとって2番目に大きな市場となっています。

調剤薬局市場 - 競合情勢

多くの分野と同様に、調剤薬局業界の競合情勢は、多くの主要企業、地域企業、地元の独立系薬局の存在によって定義されます。これらの組織は、品質、サービス範囲、規制遵守、技術向上、地理的なカバー範囲に基づいて競争することが多いです。市場シェアは、場所や各企業が占める調剤内の正確なニッチによって異なります。収益の面では、複数の拠点を持つ大企業が優位を占めるかもしれないが、地元の独立系薬局が地元のマーケットプレースで大きなシェアを占めるかもしれないです。

調剤の精度、品質管理、業務効率を向上させるために技術的な改善を行う薬局もあります。例えば、Avella Specialty Pharmacyはヒューストンを拠点とするAdvanced Pharma Inc.を買収する正式契約を締結しました。Advanced Pharma Inc.はFDAに登録された503Bアウトソーシング施設で、全国の病院、医療システム、外来手術センターに14の治療クラスにわたる配合製品を提供しています。

目次

第1章 調剤薬局市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 調剤薬局の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 調剤薬局業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 調剤薬局市場：COVID-19の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 調剤薬局市場情勢

  • 調剤薬局市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 調剤薬局市場 - 製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 経口剤
      • カプセル
      • タブレット
      • 混合
      • ロリポップ
      • トローチ
    • 局所剤
      • ジェル
      • 軟膏
      • クリーム
      • ローション
    • 直腸剤
    • 非経口剤
    • 鼻腔剤
    • 眼科剤
    • 洗口剤

第8章 調剤薬局市場 - 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 小児
    • 成人
    • 高齢者
    • 獣医

第9章 調剤薬局市場 - 配合タイプ別

  • 概要
    • セグメントシェア分析（配合タイプ別）
    • 医薬品成分の変更（PIA）
    • 現在利用できない医薬品製造（CUPM）
    • 医薬品の用量変更（PDA）
    • その他

第10章 調剤薬局市場 - 治療領域別

  • 概要
    • 治療領域別のセグメントシェア分析
    • 疼痛管理
    • ホルモン補充療法（HRT）
    • 皮膚科
    • 特殊医薬品

第11章 調剤薬局市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析 - 調剤薬局業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Avella Specialty Pharmacy
    • Central Admixture Pharmacy Services
    • Fagron
    • Fresenius Kabi AG
    • PharMEDium Services
    • Institutional Pharmacy Solutions
    • Cantrell Drug Company
    • Triangle Compounding Pharmacies
    • Lorraine's Pharmacy
    • Rx3 Compounding Pharmacy
    • B Braun Melsungen AG
    • Clinigen Group PLC
    • QuVa Pharma
    • ITC Compounding Pharmacy
    • Advanced Pharmacy.

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Compounding Pharmacies Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Compounding Pharmacies Market, by Product Type 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Compounding Pharmacies Market, by Application 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Compounding Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Compounding Type
  • TABLE Global Compounding Pharmacies Market, by Compounding Type 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Therapeutic Areas Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Areas
  • TABLE Global Compounding Pharmacies Market, by Therapeutic Areas 2018-2030 (USD Million)
  • TABLE Compounding Pharmacies Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Compounding Pharmacies Market, by Region 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE North America Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Europe Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Latin America Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Compounding Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Compounding Pharmacies Market, by Therapeutic Areas, 2018-2030 (USD Million)

List of Figures

  • FIGURE Compounding Pharmacies Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Compounding Type segment market share analysis, 2022 & 2030
  • FIGURE Compounding Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Therapeutic Areas segment market share analysis, 2022 & 2030
  • FIGURE Therapeutic Areas segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Compounding Pharmacies Market share and leading players, 2022
  • FIGURE Europe Compounding Pharmacies Market share and leading players, 2022
  • FIGURE Asia Pacific Compounding Pharmacies Market share and leading players, 2022
  • FIGURE Latin America Compounding Pharmacies Market share and leading players, 2022
  • FIGURE Middle East and Africa Compounding Pharmacies Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Compounding Pharmacies Market share analysis by country, 2022
  • FIGURE Germany Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Compounding Pharmacies Market share analysis by country, 2022
  • FIGURE India Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Compounding Pharmacies Market share analysis by country, 2022
  • FIGURE Brazil Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Compounding Pharmacies Market share analysis by country, 2022
  • FIGURE Saudi Arabia Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Compounding Pharmacies Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1658

REPORT HIGHLIGHT

Compounding Pharmacies Market size was valued at USD 12,608.7 Million in 2022, expanding at a CAGR of 6.3% from 2023 to 2030.

Compounding pharmacies have a unique and crucial function in the pharmaceutical sector. By blending, modifying, or combining two or more substances to match a patient's unique needs, pharmacists create customized prescriptions for their patients. In order to create a compounded medicine, compounding pharmacies must use only pure, pharmaceutical-grade ingredients. These have to be manufactured in a setting that has an FDA registration. Compound and conventional medications are labeled differently in several cases. unlike labels for FDA-approved pharmaceuticals, compounded medicine labels don't adhere to a specific structure. The laws governing them differ as well.

Compounding Pharmacies Market - Market Dynamics:

  • Increasing prevalence of chronic disease, increase in old age population, and improved life expectancy expected to propel market demand
  • Long-term treatment is frequently necessary for chronic disorders. Compounding pharmacies can adapt pharmaceuticals to a patient's unique requirements, maximizing dosages and forms, or otherwise improving their effectiveness or tolerability for patients with particular demands. According to the National Health Council, generally incurable and ongoing, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions. There is a greater need for specialist geriatric care as there are more senior people, both in terms of medical services and facilities designed for this age group. The emphasis on preventative medicine to ensure quality of life grows as life expectancy rises. This may strengthen the wellness, nutrition, and screening industries. Significant opportunity for development is offered by developing nations. The need for customized treatments could increase as awareness and income levels improve in these areas. However, the severe regulatory supervision that compounding pharmacies occasionally experience can be problematic. It hampers the market growth.

Compounding Pharmacies Market - Key Insights:

  • As per the analysis shared by our research analyst, the global Compounding Pharmacies market is estimated to grow annually at a CAGR of around 6.3% over the forecast period (2023-2030)
  • The Compounding Pharmacies industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Product type segmentation, Oral was predicted to show maximum market share in the year 2022
  • Based on Therapeutic Area segmentation, Hormone Replacement Therapy (HRT) was the leading type in 2022
  • Based on Application segmentation, Geriatric was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Compounding Pharmacies Market- Segmentation Analysis:

  • The Global Compounding Pharmacies Market is segmented based on Product Type, Therapeutic Areas, Application, Compounding Type, and Region.
  • The market is divided into seven categories based on product type: Oral, Topical, Rectal, Parenteral, Nasal, Ophthalmic, and Mouthwashes. The oral segment dominates the market. Due to its ease of administration, patient compliance, and diversity in formulation (such as tablets, capsules, liquids, and suspensions), the oral route remains one of the most popular drug delivery modalities.
  • The market is divided into four categories based on Therapeutic Areas: Pain Management, Hormone Replacement Therapy (HRT), Dermatology, and Specialty Drugs. Hormone Replacement Therapy (HRT) segment dominates the market. Compounding pharmacies play an important part in the field of Hormone Replacement Therapy (HRT). HRT is the use of hormones to treat hormonal abnormalities in the body, which are frequently associated with menopause, andropause (sometimes known as "male menopause"), or certain endocrine illnesses.
  • The market is divided into four categories based on Application: Pediatric, adult, Geriatric, and Veterinary. The Geriatric application dominates the market and is likely to maintain its dominance during the forecast period. Compounding pharmacies play an important part in the geriatric healthcare sector. Because of factors such as polypharmacy (taking numerous medications), age-related physiological changes, specific drug sensitivities, and drug administration problems, the aged population frequently has unique prescription needs.

Compounding Pharmacies Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, due to High regional awareness regarding compounding medications, and an increasing number of healthcare facilities. Over the years, the US and Canada have made considerable investments in healthcare infrastructure. This covers not only hospitals but also specialty clinics, nursing homes, and other care settings where compounded pharmaceuticals can be beneficial. The U.S. Health Care from a Global Perspective predicted that in 2021, the U.S. spent 17.8 percent of gross domestic product (GDP) on health care, nearly twice as much as the average OECD country. Europe is the second-largest market for Compounding Pharmacies, due to high awareness, regulatory clarity, economic strength, and technological innovation.

Compounding Pharmacies Market- Competitive Landscape:

As with many sectors, the competitive landscape of the compounding pharmacies industry is defined by the existence of many main players, regional players, and local, independent pharmacies. These organizations frequently compete on the basis of quality, service range, regulatory compliance, technical improvements, and geographic coverage. The market share will differ depending on the location and the precise niche within compounding that each company occupies. In terms of revenue, larger businesses with several locations may dominate, although local, independent pharmacies may hold major shares in local marketplaces.

Some pharmacies may use technology improvements to improve compounding precision, quality control, or operational efficiency. For Example, Avella Specialty Pharmacy has signed a definitive agreement to acquire Houston-based Advanced Pharma Inc., an FDA-registered 503B outsourcing facility providing compounded products across 14 therapeutic classes to hospitals, health systems, and ambulatory surgery centers nationwide.

Recent Developments:

On Oct. 11, 2018, Fresenius Kabi announced currently it has opened a new pharmaceutical compounding center in Mississauga, Ontario. The center features state-of-the-art manufacturing technology and processes designed to meet rigorous quality standards and increased capacity needs of customers. The facility produces compounded pharmaceuticals for Canadian hospitals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPOUNDING PHARMACIES MARKET KEY PLAYERS

  • Avella Specialty Pharmacy
  • Central Admixture Pharmacy Services
  • Fagron
  • Fresenius Kabi AG
  • PharMEDium Services
  • Institutional Pharmacy Solutions
  • Cantrell Drug Company
  • Triangle Compounding Pharmacies
  • Lorraine's Pharmacy
  • Rx3 Compounding Pharmacy
  • B Braun Melsungen AG
  • Clinigen Group PLC
  • QuVa Pharma
  • ITC Compounding Pharmacy
  • Advanced Pharmacy

GLOBAL COMPOUNDING PHARMACIES MARKET, BY PRODUCT TYPE

  • Oral
  • Capsule
  • Tablets
  • Mixtures
  • Lollipops
  • Lozenges
  • Topical
  • Gels
  • Ointments
  • Cream
  • Lotions
  • Rectal
  • Parenteral
  • Nasal
  • Ophthalmic
  • Mouthwashes

GLOBAL COMPOUNDING PHARMACIES MARKET, BY THERAPEUTIC AREA

  • Pain Management
  • Hormone Replacement Therapy (HRT)
  • Dermatology
  • Specialty Drugs

GLOBAL COMPOUNDING PHARMACIES MARKET, BY APPLICATION

  • Pediatric
  • Adults
  • Geriatric
  • Veterinary

GLOBAL COMPOUNDING PHARMACIES MARKET, BY COMPOUNDING TYPE

  • Pharmaceutical Ingredient Alteration (PIA)
  • Pharmaceutical Dosage Alteration (PDA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Others

GLOBAL COMPOUNDING PHARMACIES MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Compounding Pharmacies Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Compounding Pharmacies Market Snippet by Product Type
    • 2.1.2. Compounding Pharmacies Market Snippet by Application
    • 2.1.3. Compounding Pharmacies Market Snippet by Compounding Type
    • 2.1.4. Compounding Pharmacies Market Snippet by Therapeutic Areas
    • 2.1.5. Compounding Pharmacies Market Snippet by Country
    • 2.1.6. Compounding Pharmacies Market Snippet by Region
  • 2.2. Competitive Insights

3. Compounding Pharmacies Key Market Trends

  • 3.1. Compounding Pharmacies Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Compounding Pharmacies Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Compounding Pharmacies Market Opportunities
  • 3.4. Compounding Pharmacies Market Future Trends

4. Compounding Pharmacies Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Compounding Pharmacies Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Compounding Pharmacies Market Landscape

  • 6.1. Compounding Pharmacies Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Compounding Pharmacies Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Oral
      • 7.1.2.1. Capsule
      • 7.1.2.2. Tablets
      • 7.1.2.3. Mixtures
      • 7.1.2.4. Lollipops
      • 7.1.2.5. Lozenges
    • 7.1.3. Topical
      • 7.1.3.1. Gels
      • 7.1.3.2. Ointments
      • 7.1.3.3. Cream
      • 7.1.3.4. Lotions
    • 7.1.4. Rectal
    • 7.1.5. Parenteral
    • 7.1.6. Nasal
    • 7.1.7. Ophthalmic
    • 7.1.8. Mouthwashes

8. Compounding Pharmacies Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Pediatric
    • 8.1.3. Adults
    • 8.1.4. Geriatric
    • 8.1.5. Veterinary

9. Compounding Pharmacies Market - By Compounding Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Compounding Type, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical Ingredient Alteration (PIA)
    • 9.1.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
    • 9.1.4. Pharmaceutical Dosage Alteration (PDA)
    • 9.1.5. Others

10. Compounding Pharmacies Market - By Therapeutic Areas

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 10.1.2. Pain Management
    • 10.1.3. Hormone Replacement Therapy (HRT)
    • 10.1.4. Dermatology
    • 10.1.5. Specialty Drugs

11. Compounding Pharmacies Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Compounding Pharmacies Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Compounding Pharmacies Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Compounding Pharmacies Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Compounding Pharmacies Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Compounding Pharmacies Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Compounding Pharmacies Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Avella Specialty Pharmacy
    • 12.2.2. Central Admixture Pharmacy Services
    • 12.2.3. Fagron
    • 12.2.4. Fresenius Kabi AG
    • 12.2.5. PharMEDium Services
    • 12.2.6. Institutional Pharmacy Solutions
    • 12.2.7. Cantrell Drug Company
    • 12.2.8. Triangle Compounding Pharmacies
    • 12.2.9. Lorraine's Pharmacy
    • 12.2.10. Rx3 Compounding Pharmacy
    • 12.2.11. B Braun Melsungen AG
    • 12.2.12. Clinigen Group PLC
    • 12.2.13. QuVa Pharma
    • 12.2.14. ITC Compounding Pharmacy
    • 12.2.15. Advanced Pharmacy.

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us